Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Furuta

Showing results (501-510 of 638) with videos related to

Pageof 64
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 28, 2020
Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parametersMatthew A Rank, Rajiv N Sharaf, Glenn T Furuta, et al.
Oncogene|January 13, 2006
p21CDKN1A allows the repair of replication-mediated DNA double-strand breaks induced by topoisomerase I and is inactivated by the checkpoint kinase inhibitor 7-hydroxystaurosporineT Furuta, R L Hayward, L-H Meng, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|August 3, 2010
Embolization of cerebral arteriovenous malformations with cellulose acetate polymer. Histological study of the resected specimensK Tokunaga, K Kinugasa, T Meguro, et al.
The Journal of Clinical Investigation|October 9, 2002
Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epitheliaKristin Synnestvedt, Glenn T Furuta, Katrina M Comerford, et al.
Clinical Pharmacology and Therapeutics|October 8, 1999
Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humansT Furuta, K Ohashi, K Kobayashi, et al.
Physical Review Letters|July 15, 2003
Anisotropic ultrafast dissociation probed by the Doppler effect in resonant photoemission from CF4K Ueda, M Kitajima, A De Fanis, et al.
Clinical Pharmacology and Therapeutics|January 12, 2007
Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pyloriT Furuta, N Shirai, M Kodaira, et al.
Alimentary Pharmacology & Therapeutics|March 19, 2016
Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotypeT Kagami, S Sahara, H Ichikawa, et al.
Alimentary Pharmacology & Therapeutics|October 9, 2013
Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazoleS Sahara, M Sugimoto, T Uotani, et al.
Alimentary Pharmacology & Therapeutics|June 9, 2007
Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from JapanH Miwa, M Sasaki, T Furuta, et al.
Pageof 64

Showing results (501-510 of 638) with videos related to

Sort By:
Pageof 64
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 28, 2020
Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parametersMatthew A Rank, Rajiv N Sharaf, Glenn T Furuta, et al.
Oncogene|January 13, 2006
p21CDKN1A allows the repair of replication-mediated DNA double-strand breaks induced by topoisomerase I and is inactivated by the checkpoint kinase inhibitor 7-hydroxystaurosporineT Furuta, R L Hayward, L-H Meng, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|August 3, 2010
Embolization of cerebral arteriovenous malformations with cellulose acetate polymer. Histological study of the resected specimensK Tokunaga, K Kinugasa, T Meguro, et al.
The Journal of Clinical Investigation|October 9, 2002
Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epitheliaKristin Synnestvedt, Glenn T Furuta, Katrina M Comerford, et al.
Clinical Pharmacology and Therapeutics|October 8, 1999
Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humansT Furuta, K Ohashi, K Kobayashi, et al.
Physical Review Letters|July 15, 2003
Anisotropic ultrafast dissociation probed by the Doppler effect in resonant photoemission from CF4K Ueda, M Kitajima, A De Fanis, et al.
Clinical Pharmacology and Therapeutics|January 12, 2007
Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pyloriT Furuta, N Shirai, M Kodaira, et al.
Alimentary Pharmacology & Therapeutics|March 19, 2016
Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotypeT Kagami, S Sahara, H Ichikawa, et al.
Alimentary Pharmacology & Therapeutics|October 9, 2013
Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazoleS Sahara, M Sugimoto, T Uotani, et al.
Alimentary Pharmacology & Therapeutics|June 9, 2007
Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from JapanH Miwa, M Sasaki, T Furuta, et al.
Pageof 64